199 related articles for article (PubMed ID: 17028542)
21. Unverricht-Lundborg disease, a condition with self-limited progression: long-term follow-up of 20 patients.
Magaudda A; Ferlazzo E; Nguyen VH; Genton P
Epilepsia; 2006 May; 47(5):860-6. PubMed ID: 16686650
[TBL] [Abstract][Full Text] [Related]
22. Unverricht-Lundborg disease.
Crespel A; Ferlazzo E; Franceschetti S; Genton P; Gouider R; Kälviäinen R; Korja M; Lehtinen MK; Mervaala E; Simonato M; Vaarmann A
Epileptic Disord; 2016 Sep; 18(S2):28-37. PubMed ID: 27582036
[TBL] [Abstract][Full Text] [Related]
23. [Unverricht-Lundborg disease manifesting tremulous myoclonus with rare convulsive seizures: a case report].
Kondo T; Yamakado H; Kawamata J; Tomimoto H; Hitomi T; Takahashi R; Ikeda A
Rinsho Shinkeigaku; 2009 Jan; 49(1):43-7. PubMed ID: 19227896
[TBL] [Abstract][Full Text] [Related]
24. Progressive myoclonic epilepsies: definitive and still undetermined causes.
Franceschetti S; Michelucci R; Canafoglia L; Striano P; Gambardella A; Magaudda A; Tinuper P; La Neve A; Ferlazzo E; Gobbi G; Giallonardo AT; Capovilla G; Visani E; Panzica F; Avanzini G; Tassinari CA; Bianchi A; Zara F;
Neurology; 2014 Feb; 82(5):405-11. PubMed ID: 24384641
[TBL] [Abstract][Full Text] [Related]
25. Perampanel in 12 patients with Unverricht-Lundborg disease.
Crespel A; Gelisse P; Tang NP; Genton P
Epilepsia; 2017 Apr; 58(4):543-547. PubMed ID: 28166365
[TBL] [Abstract][Full Text] [Related]
26. Molecular background of progressive myoclonus epilepsy.
Lehesjoki AE
EMBO J; 2003 Jul; 22(14):3473-8. PubMed ID: 12853462
[TBL] [Abstract][Full Text] [Related]
27. Neurophysiology of Juvenile and Progressive Myoclonic Epilepsy.
Acharya JN; Acharya VJ
J Clin Neurophysiol; 2023 Feb; 40(2):100-108. PubMed ID: 36735458
[TBL] [Abstract][Full Text] [Related]
28. Variable course of Unverricht-Lundborg disease: Early prognostic factors.
Canafoglia L; Ferlazzo E; Michelucci R; Striano P; Magaudda A; Gambardella A; Pasini E; Belcastro V; Riguzzi P; Fanella M; Granata T; Beccaria F; Trentini C; Bianchi A; Aguglia U; Panzica F; Franceschetti S
Neurology; 2017 Oct; 89(16):1691-1697. PubMed ID: 28931642
[TBL] [Abstract][Full Text] [Related]
29. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene.
Koskenkorva P; Hyppönen J; Aikiä M; Mervaala E; Kiviranta T; Eriksson K; Lehesjoki AE; Vanninen R; Kälviäinen R
Neurodegener Dis; 2011; 8(6):515-22. PubMed ID: 21757863
[TBL] [Abstract][Full Text] [Related]
30. Unverricht-Lundborg disease with cystatin B gene abnormalities.
Kagitani-Shimono K; Imai K; Okamoto N; Ono J; Okada S
Pediatr Neurol; 2002 Jan; 26(1):55-60. PubMed ID: 11814737
[TBL] [Abstract][Full Text] [Related]
31. Electroclinical presentation and genotype-phenotype relationships in patients with Unverricht-Lundborg disease carrying compound heterozygous CSTB point and indel mutations.
Canafoglia L; Gennaro E; Capovilla G; Gobbi G; Boni A; Beccaria F; Viri M; Michelucci R; Agazzi P; Assereto S; Coviello DA; Di Stefano M; Rossi Sebastiano D; Franceschetti S; Zara F
Epilepsia; 2012 Dec; 53(12):2120-7. PubMed ID: 23205931
[TBL] [Abstract][Full Text] [Related]
32. The Roles of Cystatin B in the Brain and Pathophysiological Mechanisms of Progressive Myoclonic Epilepsy Type 1.
Singh S; Hämäläinen RH
Cells; 2024 Jan; 13(2):. PubMed ID: 38247861
[TBL] [Abstract][Full Text] [Related]
33. Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS).
Möller JC; Hamer HM; Oertel WH; Rosenow F
Seizure; 2002 Apr; 11 Suppl A():303-5. PubMed ID: 12185765
[TBL] [Abstract][Full Text] [Related]
34. Progressive myoclonic epilepsies: it takes a village to make a diagnosis.
Knupp K; Wirrell E
Neurology; 2014 Feb; 82(5):378-9. PubMed ID: 24384640
[TBL] [Abstract][Full Text] [Related]
35. Primary motor cortex alterations in a compound heterozygous form of Unverricht-Lundborg disease (EPM1).
Danner N; Julkunen P; Könönen M; Hyppönen J; Koskenkorva P; Vanninen R; Lehesjoki AE; Kälviäinen R; Mervaala E
Seizure; 2011 Jan; 20(1):65-71. PubMed ID: 21075014
[TBL] [Abstract][Full Text] [Related]
36. Sensorimotor cortex excitability in Unverricht-Lundborg disease and Lafora body disease.
Canafoglia L; Ciano C; Panzica F; Scaioli V; Zucca C; Agazzi P; Visani E; Avanzini G; Franceschetti S
Neurology; 2004 Dec; 63(12):2309-15. PubMed ID: 15623692
[TBL] [Abstract][Full Text] [Related]
37. Haplotype study of West European and North African Unverricht-Lundborg chromosomes: evidence for a few founder mutations.
Moulard B; Genton P; Grid D; Jeanpierre M; Ouazzani R; Mrabet A; Morris M; LeGuern E; Dravet C; Mauguière F; Utermann B; Baldy-Moulinier M; Belaidi H; Bertran F; Biraben A; Ali Chérif A; Chkili T; Crespel A; Darcel F; Dulac O; Geny C; Humbert-Claude V; Kassiotis P; Buresi C; Malafosse A
Hum Genet; 2002 Sep; 111(3):255-62. PubMed ID: 12215838
[TBL] [Abstract][Full Text] [Related]
38. A Native Haitian Woman with Unverricht-Lundborg Disease.
Mohamadpour M; Gabriel G; Grant AC
Case Rep Neurol; 2017; 9(3):284-288. PubMed ID: 29422850
[TBL] [Abstract][Full Text] [Related]
39. Progressive myoclonus epilepsy of Unverricht-Lundborg type.
Lehesjoki AE; Koskiniemi M
Epilepsia; 1999; 40 Suppl 3():23-8. PubMed ID: 10446747
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
